We also noticed that the lysine-187 residue of TIRR, its ubiquitination site, was mutated to arginine in patient samples from TCGA, indicating that TIRR could be mutated in cancer and that TIRR mutation could contribute to disease progression. The gene discussed is NUDT16L1; the disease is cancer.